Lunai Bioworks Inc. (LNAI)
$1.03-7.21%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 0.35
- P/E (TTM)
- -0.02
- Short % float
- 5.88%
- Days to cover
- 2.6
- SI change
- +10.8%
- 1W
- -8.85%
- 1M
- -52.53%
- vs SPY 1W
- -8.71%
- vs SPY 1M
- -55.04%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on LNAI?
- LOPJLB’s latest quantitative signal on Lunai Bioworks Inc. (LNAI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LNAI in?
- Lunai Bioworks Inc. (LNAI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lunai Bioworks Inc. (LNAI) do?
- Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."